Regeneron Pharmaceuticals, Inc., a biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions, is a Visionary Partner of the American Diabetes Association® Eye Health Initiative, Focus on Diabetes and a Banting Circle Elite Partner. Together with the ADA, Regeneron joins this new initiative with the goal of reducing the risk of diabetes-related eye disease through increased awareness, screening, prevention and early intervention.

Novo Nordisk is a National Strategic Partner of ADA Camps. They help to provide annual financial support to families needing economic assistance to attend Camp programs across the country. Novo Nordisk also continues to support Scientific Sessions, the world's largest meeting on diabetes. The company is a founding sponsor of Pathway To Stop Diabetes, a research program designed to find the next generation of diabetes researchers and continues to support this program.

In addition, Novo continues to support Know Diabetes By Heart, which is a collaboration between the American Diabetes Association and the American Heart Association, Phase three of Therapeutic Inertia, a 3-year, comprehensive, multi-faceted campaign that encompasses a wide range of stakeholders, to significantly bend the curve and help improve the lives of those with diabetes and lastly, Diabetes Is Primary programs that deliver easily accessible continuing education to meet the needs of busy primary care providers.

Website: novonordisk-us.com

Sanofi is a founding sponsor of Pathway To Stop Diabetes, a research program designed to find the next generation of diabetes researchers by funding bold and novel approaches in addressing the diabetes epidemic. The company supports Diabetes is Primary, a one-day educational event for the primary care community that is available to clinicians year-round online.

In addition, Sanofi continues to support Know Diabetes By Heart, which is a collaboration between the American Diabetes Association and the American Heart Association, as well as Phase three of Therapeutic Inertia, a 3-year, comprehensive, multi-faceted campaign that encompasses a wide range of stakeholders, to significantly bend the curve and help improve the lives of those with diabetes.

Website: https://www.sanofi.us/en

Abbott Diabetes Care is a supporter of our Diabetes Is Primary programs nationwide. This continuing education program provides Primary Care Physicians with a full-day educational experience to learn about updates within the American Diabetes Association’s Standards of Medical Care in Diabetes.

Abbott continues to support diabetes research through our Pathway to Stop Diabetes campaign and Diabetes Inside, a national, multi-sector population health initiative designed to sustain long-term engagement by healthcare stakeholders to regularly share learnings with a broad professional network to scale successful changes and disrupt the status quo in chronic disease management. In addition, Abbott is a supporter of Time In Range, the American Diabetes Association’s nationwide effort to encourage measuring and monitoring of blood glucose levels ‘beyond A1C’ to improve outcomes and better manage diabetes.

AstraZeneca supported Product Theaters and Corporate Symposia at Scientific Sessions, the world's largest annual research and clinical meeting on diabetes. AstraZeneca also supported Diabetes Is Primary Core Programs that deliver easily accessible continuing education to meet the needs of busy primary care providers and Phase three of Therapeutic Inertia, a 3-year, comprehensive, multi-faceted campaign that encompasses a wide range of stakeholders, to significantly bend the curve and help improve the lives of those living with diabetes.

Website: astrazeneca.com

Eli Lilly provides annual financial support to families needing economic assistance to attend diabetes Camp programs. They are also a supporter of Postgraduate Course, a meeting to learn more about the advancements in diabetes management. Through the Eli Lilly & Company Foundation, the company is a founding sponsor of Pathway To Stop Diabetes, a research program designed to find the next generation of diabetes researchers.

Website: lilly.com

Merck supports diabetes research through Pathway to Stop Diabetes, the Association's program designed to find the next generation of diabetes researchers. Merck is also supporting Diabetes Is Primary Core Programs that deliver easily accessible continuing education to meet the needs of busy primary care providers and Phase three of Therapeutic Inertia, a 3-year, comprehensive, multi-faceted campaign that encompasses a wide range of stakeholders, to significantly bend the curve and help improve the lives of those with diabetes. Merck is a strong supporter of the Association's Scientific Sessions, the world's largest meeting in diabetes, and supported two awards: the Albert Renold Award given for achievement in diabetes research and the Kelly West Award which is awarded for excellence in the field of diabetes epidemiology.

Website: merck.com